Features | Partner Sites | Information | LinkXpress
Sign In

Abbott Showcases Innovations, Helps Labs Solve Health Care Challenges

By Labmedica International staff writers
Posted on 29 Jul 2014
Clinical laboratories around the world are helping to improve patient care while navigating an evolving health care environment. Abbott (Abbott Park, IL, USA) will present more than 40 scientific presentations and/or posters related to the company's solutions to these challenges. A complete list of Abbott's presentations, posters and workshops can be found online (please see Related Links below). The company is developing diagnostic solutions, which it will showcase during the American Association for Clinical Chemistry (AACC 2014) annual meeting and clinical lab expo.

During the AACC meeting, Abbott will feature a variety of innovations focused on increased testing volumes and improving efficiencies: for the core lab, Abbott recently launched a next generation automation solution, the Acceleratora3600, which doubles per-hour processing capacity compared to previous systems. Studies have shown a core lab can eliminate a significant percentage of associated operating costs through automation and standardization of testing. Abbott's m2000 RealTime System for automated infectious disease molecular testing gives labs the ability to handle greater volumes at reduced costs on a single platform. Labs that use Abbott's molecular automated solutions may process the same number of tests with fewer instruments.

Used at a patient's bedside, the i-STAT point-of-care (POC) system allows physicians and nurses to quickly and accurately analyze lab-quality results within minutes, rather than hours, to accelerate decision-making and ensure patients receive the most effective and efficient care.

Abbott provides laboratories with a powerful suite of informatics solutions to manage large volumes of data across health care systems, helping labs simplify complex processes to make information actionable. Hospitals, reference labs, and blood banks use Abbott's informatics technology to help treat and monitor various diseases and medical conditions.

Related Links:

Abbott
Abbott Diagnostics



DiagCor Bioscience
ADVANCED INSTRUMENTS
comments powered by Disqus
Life Technologies

Channels

Immunology

view channel
Image: The Zinc Transporter 8 Autoantibody (ZnT8Ab) enzyme-linked immunosorbent assay (ELISA) kit (Photo courtesy of KRONUS).

Autoantibody Test Helps Diagnose Type 1 Diabetes

The first zinc transporter 8 autoantibody (ZnT8Ab) test has been approved for marketing and the test can help determine if a person has diabetes mellitus type 1 and not another type of diabetes.... Read more

Industry News

view channel

First European Company Obtains CE-IVD Marking for Next Generation Sequencing in Routine Testing

For the first time, a European company, Sophia Genetics (Lausanne Switzerland), has obtained the CE-IVD mark for clinical use of Next Generation Sequencing (NGS) bioinformatics pipeline for routine genetic testing. Sophia Genetics received this CE-IVD mark shortly after receiving ISO 13485 accreditation.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.